Published online 1 July 2004
Nucleic Acids Research, Vol. 32 No. 11 © Oxford University Press 2004; all rights reserved
Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity
Cancer Research UK Department of Oncology, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2XY, UK
* To whom correspondence should be addressed. Tel: +44 1223 336909; Fax: +44 1223 763231; Email: djw{at}mole.bio.cam.ac.uk
Received April 22, 2004; Revised and Accepted June 4, 2004
Somatically inducible Cre lines are used extensively to study gene function. However, a background level of spontaneous recombination due to unregulated expression of Cre is particularly confounding for cancer models in which following the pathogenesis of the disease requires the introduction of sporadic mutations that are monitored over time. In three transgenic mouse lines, two with Cre activity controlled at the transcriptional level (Ahcre, Mx1cre), and one controlled at the protein level (R26creERT), we have identified sporadic recombination at the R26R reporter locus in multiple tissues. Detailed analysis of the intestinal epithelium suggests that recombination can occur both during development and as an ongoing process in adult life. Here we present a new inducible Cre transgenic line, AhcreERT, in which control of Cre activity is regulated at two levels: by transcriptional control of the Ah promoter and by a requirement for Tamoxifen binding. There is no detectable background intestinal recombination in adult AhcreERT mice on the R26R background. Inducible and dose-dependent recombination can be achieved by a single combined treatment with ß-napthoflavone and Tamoxifen.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Haldar, M. L. Hedberg, M. F. Hockin, and M. R. Capecchi A CreER-Based Random Induction Strategy for Modeling Translocation-Associated Sarcomas in Mice Cancer Res., April 15, 2009; 69(8): 3657 - 3664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Waning, B. Li, N. Jia, Y. Naaldijk, W. S. Goebel, H. HogenEsch, and K. T. Chun Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis Blood, July 15, 2008; 112(2): 320 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hameyer, A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E. Bindels, J. Jonkers, P. Krimpenfort, R. Meuwissen, et al. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues Physiol Genomics, September 11, 2007; 31(1): 32 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paulmurugan and S. S. Gambhir An intramolecular folding sensor for imaging estrogen receptor-ligand interactions PNAS, October 24, 2006; 103(43): 15883 - 15888. [Abstract] [Full Text] [PDF] |
||||



